Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
Fractyl Health (Nasdaq: GUTS) will report third quarter 2025 financial results and provide business updates on Wednesday, November 12, 2025 at 4:30 p.m. ET. A live webcast of the conference call and presentation will be available in the Events section of Fractyl Health’s investor website at http://ir.fractyl.com. The webcast will be archived and available for replay following the live event.
Fractyl Health (Nasdaq: GUTS) terrà i risultati finanziari del terzo trimestre 2025 e fornirà aggiornamenti sull'attività mercoledì 12 novembre 2025 alle 16:30 ET. Una trasmissione web in diretta della conference call e della presentazione sarà disponibile nella sezione Eventi del sito investitori di Fractyl Health all'indirizzo http://ir.fractyl.com. La trasmissione sarà archiviata e disponibile per la riproduzione dopo l'evento dal vivo.
Fractyl Health (Nasdaq: GUTS) reportará los resultados financieros del tercer trimestre de 2025 y proporcionará actualizaciones comerciales el miércoles 12 de noviembre de 2025 a las 4:30 p.m. ET. Una webcast en vivo de la llamada de conferencia y la presentación estará disponible en la sección Eventos del sitio web de inversores de Fractyl Health en http://ir.fractyl.com. La transmisión en vivo será archivada y estará disponible para su reproducción tras el evento en vivo.
Fractyl Health (Nasdaq: GUTS)는 2025년 3분기 재무 실적을 발표하고 2025년 11월 12일 수요일 오후 4:30 ET에 비즈니스 업데이트를 제공합니다. 컨퍼런스 콜과 프레젠테이션의 라이브 웹캐스트는 Fractyl Health 투자자 웹사이트의 Events 섹션에서 http://ir.fractyl.com으로 이용 가능하며, 라이브 이벤트 이후에도 재생을 위해 보관됩니다.
Fractyl Health (Nasdaq: GUTS) publiera les résultats financiers du troisième trimestre 2025 et fournira des mises à jour sur les activités le mercredi 12 novembre 2025 à 16 h 30 HNE. Une webdiffusion en direct de l'appel conférence et de la présentation sera disponible dans la section Événements du site investisseurs de Fractyl Health à l'adresse http://ir.fractyl.com. La diffusion sera archivée et disponible en replay après l'événement en direct.
Fractyl Health (Nasdaq: GUTS) wird die finanziellen Ergebnisse des dritten Quartals 2025 bekannt geben und Geschäftsupdates am Mittwoch, den 12. November 2025 um 16:30 Uhr ET bereitstellen. Ein Live-Webcast der Konferenzschaltung und der Präsentation wird im Events-Bereich der Investoren-Website von Fractyl Health unter http://ir.fractyl.com verfügbar sein. Der Webcast wird archiviert und nach dem Live-Ereignis zur Wiedergabe verfügbar sein.
Fractyl Health (Nasdaq: GUTS) ستعلن عن النتائج المالية للربع الثالث من 2025 وستقدم تحديثات الأعمال في الأربعاء 12 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة. سيكون هناك بث ويب مباشر للمكالمة الصحفية والعرض في قسم الأحداث على موقع Fractyl Health للمستثمرين على http://ir.fractyl.com. سيُوثَّق البث وسيكون متاحًا لإعادة التشغيل بعد الحدث المباشر.
- None.
- None.
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the third quarter 2025 and provide business updates on Wednesday, November 12, 2025, at 4:30 p.m. ET.
A live webcast of the conference call and presentation can be accessed in the “Events” section of Fractyl Health’s website at http://ir.fractyl.com. The webcast will be archived and available for replay following the live event.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. The Company has a robust and growing IP portfolio, with 33 granted U.S. patents and approximately 40 pending U.S. applications, along with numerous foreign issued patents and pending applications. Fractyl is based in Burlington, MA. For more information, visit www.fractyl.com.
Contacts
Media Contact
Jessica Cotrone, Head of Corporate Communications
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Brian Luque, Head of Investor Relations and Corporate Development
IR@fractyl.com, 951.206.1200
FAQ
When will Fractyl Health (GUTS) report Q3 2025 results?
How can I watch the Fractyl Health (GUTS) Q3 2025 earnings webcast?
Will the Fractyl Health (GUTS) webcast be available after the live event?
What is Fractyl Health (GUTS) focused on?
Where on the Fractyl Health site is the webcast posted for investors?
